144,483 members

Skip to content. | Skip to navigation

News

Should drug prices differ by indication?

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Should drug prices differ by indication?

Increasingly, scientific advances are delivering new medicines that deliver improved survival and quality of life across multiple treatment indications.

Indication-based pricing (IBP) has been proposed as a way to better link price with value. This paper outlines the major issues, including the potential benefits of IBP, potential drawbacks, and considerations for implementation.